If you missed our pediatric lymphoblastic leukemia symposium in Jerusalem, download the meeting slides and see what our expert faculty covered at Examining Successes and Seeking New Strategies in Pediatric Acute Lymphoblastic Leukemia held in conjunction with the 28th Annual Meeting of the International BFM Study Group.
May 11, 2017
May 11, 2018
After successful completion of this educational activity, participants should be able to:
- Select an appropriate first-line treatment strategy for pediatric patients with ALL based on recent clinical trial data and expert recommendations, including considerations for “pediatric-inspired” therapy for adolescent patients
- Describe the importance of eliminating minimal residual disease and the role it plays in treatment selection throughout the management of ALL
- Identify an effective treatment approach for patients with relapsed/refractory ALL, including considerations for reinduction, prognostic factors, and incorporation of emerging therapies
This educational activity is supported by a grant from Shire.
Enduring Materials From a Certified Activity
This enduring material, derived from a certified live event, contains content that is evidence-based, balanced, and free of commercial bias. While the content was planned and implemented by prIME Oncology for a certified live event, this activity does not offer continuing education credit.
This activity is provided by prIME Oncology.